Hormone replacement therapy and false positive recall in the Million Women Study: Patterns of use, hormonal constituents and consistency of effect

Breast Cancer Research

Volumn 8, Issue 1, 2005, Pages

  Banks, Emily ^a   Reeves, Gillian ^b   Beral, Valerie ^b   Bull, Diana ^b   Crossley, Barbara ^b   Simmonds, Moya ^b   Hilton, Elizabeth ^b   Bailey, Stephen ^c   Barrett, Nigel ^d   Briers, Peter ^e   English, Ruth ^f   Jackson, Alan ^g   Kutt, Elizabeth ^h   Lavelle, Janet ⁱ   Rockall, Linda ^j   Wallis, Matthew G ^k   Wilson, Mary ^l   Patnick, Julietta ^m  

^a The Australian National University   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WORCESTERSHIRE HEALTH AND CARE NHS TRUST   (United Kingdom)

^d CHARING CROSS HOSPITAL   (United Kingdom)

^e Linton House   (United Kingdom)

^f CHURCHILL HOSPITAL   (United Kingdom)

^g QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^h Central Health Clinic   (United Kingdom)

ⁱ ROYAL LANCASTER INFIRMARY   (United Kingdom)

^j WORTHING HOSPITAL   (United Kingdom)

^k Hospital of Coventry and Warwickshire   (United Kingdom)

^l WITHINGTON HOSPITAL   (United Kingdom)

^m NATIONAL HEALTH SERVICE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORGESTREL; TIBOLONE;

ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG USE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; QUESTIONNAIRE; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; UNITED KINGDOM;

EID: 33646849003     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1364     Document Type: Article

References (35)

1. Million Women Study Collaborators: Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. BJOG 2002, 109:1319-1330.
2. Banks E: Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review. J Med Screen 2001, 8:29-35.
3. Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, English R, et al.: Impact of use of hormone replacement therapy on false positive recall in the Million Women Study. BMJ 2004, 328:1291-1292.
4. The Million Women Study Collaborative Group: The Million Women Study: design and characteristics of the study population. Breast Cancer Res 1999, 1:73-80.
5. Million Women Study Collaborators [http://www.millionwomenstudy.org]
6. British Medical Association and the Royal Pharmaceutical Society of Great Britain: British National Formulary. London 37th edition. 1999.
7. Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, English R, et al.: Predictors of outcome of mammography in the National Health Service Breast Screening Programme. J Med Screen 2002, 9:74-82.
8. Laya MB, Larson EB, Taplin SH, White E: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996, 88:643-649.
9. Thurfjell E, Holmberg L, Persson I: Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 1997, 203:339-341.
10. Christiansen C, Wang F, Barton MB, Kreuter W, Elmore J, Gelfand A, Fletcher S: Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst 2000, 92:1657-1666.
11. Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, Bull D, Elliman J, Lole Harris C: Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat 2001, 6:357-363.
12. Chlebowski R, Hendrix S, Langer R, Stefanick M, Gass M, Lane D, Rodabough R, Gilligan MA, Cyr M, et al.: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 2003, 289:3243-3253.
13. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE: Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990, 174:487-490.
14. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L: Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995, 196:433-437.
15. Greendale GA, Reboussin BA, Sie A, Singh R, Olson LK, Gatewood OM, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E, for the Postmenopausal Estrogen/Progestin Interventions (PEPI) investigators: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Int Med 1999, 130:262-269.
16. Colacurci N, Fornaro F, De Franciscis P, Palermo M, del Veccio W: Effects of different types of hormone replacement therapy on mammographic density. Maturitas 2001, 40:159-164.
17. Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B: Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999, 181:348-352.
18. Sendag F, Terek M, Ozsener S, Oztekin K, Bilgin O, Bilgen I, Memis A: Mammographic density changes during different postmenopausal hormone replacement therapies. Fertil Steril 2001, 76:445-450.
19. Ozdemir A, Konus O, Nas T, Erbas G, Cosar S, Isik S: Mammographic and ultrasonographic study of changes in the breast related to HRT. Int J Gynaecol Obstet 1999, 67:23-32.
20. Persson I, Thurfjell E, Holmberg L: Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997, 15:3201-3207.
21. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike M, Ursin G: Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003, 95:30-37.
22. Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo S, Walls E, Zeng J: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen or placebo. J Natl Cancer Inst 2001, 93:51-56.
23. The Women's Health Initiative Steering Committee: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004, 291:1701-1712.
24. Erel C, Elter K, Akman C, Ersavasti G, Altug A, Seyisoglu H, Ertungealp E: Mammographic changes in women receiving tibolone therapy. Fertil Steril 1998, 69:870-875.
25. Bruce D, Robinson J, McWilliams S, Reddy M, Fentiman IS, Rymer JM: Long-term effects of tibolone on mammographic density. Fertil Steril 2004, 82:1343-1347.
26. Valdivia I, Campodonico I, Tapia A, Capetillo M, Espinoza A, Lavin P: Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women. Fertil Steril 2004, 81:617-623.
27. Lundstrom E, Christow A, Kersemaekers W, Svane G, Azavedo E, Soderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B, et al.: Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002, 186:717-722.
28. Marchesoni D, Driul L, Ianni A, Fabiani G, Della Martina M, Zuiani C, Bazzocchi M: Postmenopausal hormone therapy and mammographic breast density. Maturitas 2005, 53:59-64.
29. Cockburn J, Staples M, Hurley SF, De Luise T: Psychological consequences of screening mammography. J Med Screen 1994, 1:7-12.
30. Ong G, Austoker J, Brett J: Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen 1997, 4:158-168.
31. Lidbrink E, Elfving J, Frisell J, Jonsson E: Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ 1996, 312:273-276.
32. Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427. [erratum Lancet 2003, 362: 1160]
33. Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, English R, et al.: How personal characteristics of individual women influence the sensitivity and specificity of mammography in the Million Women Study: cohort study. BMJ 2004, 329:477-0.
34. Beral V, Banks E, Reeves G, Green J, Gathani T, Bull D, Crossley B: The effect of hormone replacement therapy on breast and other cancers. In Menopause and Hormone Replacement, Proceedings of the Forty Seventh Study Group of the Royal College of Obstetricians and Gynaecologists Edited by: Critchley HOD, Beral V, Gebbie A. London: The Royal College of Obstetricians and Gynaecologists; 2004:136-150.
35. Cohen MEL: Effect of hormone replacement therapy on cancer detection by mammography. Lancet 1997, 349:1624.